Featured Research

from universities, journals, and other organizations

Common Virus May Contribute To Uncommon Bone Disease In Children

Date:
March 10, 2004
Source:
Childrens Hospital Of Philadelphia
Summary:
A common virus may play a major role in causing a painful disease of immune cells that attacks children's bones, according to a new study. The research may eventually lead to an easier diagnosis and to more effective treatments of the disease, Langerhans cell histiocytosis.

A common virus may play a major role in causing a painful disease of immune cells that attacks children's bones, according to a new study. The research may eventually lead to an easier diagnosis and to more effective treatments of the disease, Langerhans cell histiocytosis.

Related Articles


Researchers found evidence of the virus, human herpesvirus 6 (HHV-6) in the tissues of 25 of 35 children with Langerhans cell histiocytosis (LCH), compared to virus detected in only five of 19 children without LCH. The research team, led by John P. Dormans, M.D., director of Orthopaedic Surgery at The Children's Hospital of Philadelphia, published its findings in the January/February issue of the Journal of Pediatric Orthopaedics.

Langerhans cells, found in the blood, play an active role in the immune system. An uncontrolled excess of Langerhans cells leads to LCH, with effects that range from a limited, spontaneously resolving illness to a chronic, life-threatening disease involving multiple organ systems. Although rare, occurring in approximately five children per million, LCH most commonly strikes bone, causing painful lesions or fractures.

"LCH is called the 'great imitator' because it resembles particular bone cancers," said Dr. Dormans. "Fortunately, most children survive the disease these days." Most bone lesions resolve on their own without treatment. In other cases, surgeons successfully treat the disease by removing the abnormal area of bone.

However, successful treatment may elude physicians when LCH is chronic and affects multiple systems. Chemotherapy may succeed, at least temporarily, but only for 50 to 60 percent of patients. The cause of LCH remains unknown, and the Children's Hospital researchers investigated its origins, with the goal of advancing treatments.

"It's important to define whether LCH is primarily a tumor-like process or a reactive process, that is, one in which the immune system reacts to an infection or other insult," said Michael P. Glotzbecker, of the University of Pennsylvania School of Medicine, and the first author of the study. "Our research strengthens the case for a reaction to infection. Understanding the origin of the disease may help redefine the best treatment."

Previous researchers had proposed a role for HHV-6 infection in LCH, but the evidence was indirect, or was questioned on grounds of possible contamination. The current study was the first to identify the virus in the cytoplasm of immune cells called lymphocytes within LCH tissues. "Our findings suggest that after the HHV-6 virus infects lymphocytes, the body mounts an abnormal immune response resulting in the overproduction of Langerhans cells seen in LCH," said Mr. Glotzbecker. The researchers confirmed the presence of the virus with in situ hybridization, a testing technique.

The virus, HHV-6, is extremely common in children and adults, but usually is cleared out of the body or neutralized by a normally functioning immune system. In fact, the researchers found evidence of the virus in 5 of 18 tissue samples from children without LCH. "Because HHV-6 infection is so prevalent, but so few children get LCH, our results suggest that the virus interacts with some underlying predisposition to the disease," said Dr. Dormans.

"We don't know what may cause a predisposition to this disease," continued Dr. Dormans, "but rethinking the cause of LCH may ultimately shift treatment away from chemotherapy toward antiviral treatments or approaches that modify the immune system." Much further research is necessary, he added, but in addition to guiding treatment, future research may lead to a simple blood test to diagnose the disease. "Such a test would be less invasive and certainly less painful for children than the tissue biopsy that we now must perform to diagnose LCH."

The National Institute of Child Health and Human Development provided support for part of the research. In addition to Dr. Dormans and Mr. Glotzbecker, the study's third co-author is David F. Carpentieri, M.D., formerly a pathologist at The Children's Hospital of Philadelphia, and now at Phoenix Children's Hospital.

Founded in 1855 as the nation's first pediatric hospital, The Children's Hospital of Philadelphia is ranked today as the best pediatric hospital in the nation by U.S.News & World Report and Child magazine. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals and pioneering major research initiatives, Children's Hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country, ranking second in National Institutes of Health funding. In addition, its unique family-centered care and public service programs have brought the 430-bed hospital recognition as a leading advocate for children and adolescents from before birth through age 19. For more information, visit http://www.chop.edu.


Story Source:

The above story is based on materials provided by Childrens Hospital Of Philadelphia. Note: Materials may be edited for content and length.


Cite This Page:

Childrens Hospital Of Philadelphia. "Common Virus May Contribute To Uncommon Bone Disease In Children." ScienceDaily. ScienceDaily, 10 March 2004. <www.sciencedaily.com/releases/2004/03/040309074220.htm>.
Childrens Hospital Of Philadelphia. (2004, March 10). Common Virus May Contribute To Uncommon Bone Disease In Children. ScienceDaily. Retrieved October 31, 2014 from www.sciencedaily.com/releases/2004/03/040309074220.htm
Childrens Hospital Of Philadelphia. "Common Virus May Contribute To Uncommon Bone Disease In Children." ScienceDaily. www.sciencedaily.com/releases/2004/03/040309074220.htm (accessed October 31, 2014).

Share This



More Health & Medicine News

Friday, October 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins